FIGLA
gene geneOn this page
Also known as bHLHc8Figalpha
Summary
FIGLA (folliculogenesis specific bHLH transcription factor, HGNC:24669) is a protein-coding gene on chromosome 2p13.3, encoding Factor in the germline alpha (Q6QHK4). Germline specific transcription factor implicated in postnatal oocyte-specific gene expression.
This gene encodes a protein that functions in postnatal oocyte-specific gene expression. The protein is a basic helix-loop-helix transcription factor that regulates multiple oocyte-specific genes, including genes involved in folliculogenesis and those that encode the zona pellucida. Mutations in this gene cause premature ovarian failure type 6.
Source: NCBI Gene 344018 — RefSeq curated summary.
At a glance
- Gene–disease (curated): premature ovarian failure 6 (Strong, GenCC)
- GWAS associations: 1
- Clinical variants (ClinVar): 88 total — 4 pathogenic, 2 likely-pathogenic
- Phenotypes (HPO): 30
- MANE Select transcript:
NM_001004311
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24669 |
| Approved symbol | FIGLA |
| Name | folliculogenesis specific bHLH transcription factor |
| Location | 2p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bHLHc8, Figalpha |
| Ensembl gene | ENSG00000183733 |
| Ensembl biotype | protein_coding |
| OMIM | 608697 |
| Entrez | 344018 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000332372
RefSeq mRNA: 1 — MANE Select: NM_001004311
NM_001004311
CCDS: CCDS46320
Canonical transcript exons
ENST00000332372 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001296883 | 70787649 | 70787801 |
| ENSE00001316438 | 70790408 | 70790643 |
| ENSE00001320722 | 70785415 | 70785639 |
| ENSE00001475245 | 70777637 | 70777671 |
| ENSE00001754342 | 70777310 | 70777382 |
Expression profiles
Bgee: expression breadth broad, 75 present calls, max score 96.24.
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 96.24 | gold quality |
| secondary oocyte | CL:0000655 | 93.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.67 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.86 | gold quality |
| body of pancreas | UBERON:0001150 | 49.84 | gold quality |
| oviduct epithelium | UBERON:0004804 | 46.87 | silver quality |
| mucosa of stomach | UBERON:0001199 | 43.38 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| myometrium | UBERON:0001296 | 43.22 | gold quality |
| granulocyte | CL:0000094 | 42.81 | silver quality |
| omental fat pad | UBERON:0010414 | 41.90 | gold quality |
| peritoneum | UBERON:0002358 | 41.89 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 41.82 | gold quality |
| body of uterus | UBERON:0009853 | 41.79 | gold quality |
| pancreas | UBERON:0001264 | 41.71 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| right ovary | UBERON:0002118 | 41.08 | gold quality |
| sperm | CL:0000019 | 40.98 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8381 | yes | 994.15 |
| E-ANND-3 | no | 0.97 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
6 targets.
| Target | Regulation |
|---|---|
| FIGLA | |
| MIR212 | |
| TCF3 | Unknown |
| ZP1 | Unknown |
| ZP2 | Unknown |
| ZP3 | Unknown |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0820.1 | FIGLA | Tal-related |
| MA0820.2 | FIGLA | Tal-related |
| MA1934.1 | ERF::FIGLA | Ets-related::Tal-related |
| MA1934.2 | ERF::FIGLA | Ets-related::Tal-related |
| MA1941.1 | ETV2::FIGLA | Ets-related::Tal-related |
| MA1941.2 | ETV2::FIGLA | Ets-related::Tal-related |
| MA1945.1 | ETV5::FIGLA | Ets-related::Tal-related |
| MA1945.2 | ETV5::FIGLA | Ets-related::Tal-related |
JASPAR matrix evidence (PMIDs): PMID:18499083, PMID:31913281, PMID:24218641
Upstream regulators (CollecTRI, top): FIGLA
Literature-anchored findings (GeneRIF, showing 7)
- Expression of mRNA observed in ovarian follicles, mature oocytes, and less frequently in preimplantation embryos. (PMID:12468641)
- These results suggest that FIGLA is involved in continued oocyte survival as primordial follicles form in the human as in the rodent ovary. (PMID:15044608)
- the p.140 delN mutation disrupted FIGLA binding to the TCF3 helix-loop-helix (HLH) domain. Our findings show that a subset of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA. (PMID:18499083)
- may have a role in the development of primordial follicle before zona pellucida formation (PMID:18502569)
- study identified an association between FIGLA gene variants and the occurrence of premature ovarian failure(POF) in the Indian population; findings suggest that the c.427G->C and c.557C->T alleles lead to an increased risk of POF in Indian women (PMID:25314148)
- Biallelic mutations in FIGLA may be the cause of premature ovarian insufficiency (POI) . This study will aid researchers and clinicians in genetic counseling of POI and provides new insights into understanding the mode of genetic inheritance of FIGLA mutations in POI pathology. (PMID:29914564)
- Our results support the notion that bi-allelic recessive loss-of-function effects of FIGLA contribute to POI patients with short stature and expand the FIGLA-related phenotypic spectrum. (PMID:30474133)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | figla | ENSDARG00000087166 |
| mus_musculus | Figla | ENSMUSG00000030001 |
| rattus_norvegicus | Figla | ENSRNOG00000015877 |
| drosophila_melanogaster | twi | FBGN0003900 |
| caenorhabditis_elegans | WBGENE00001953 |
Paralogs (13): HAND1 (ENSG00000113196), TCF21 (ENSG00000118526), TWIST1 (ENSG00000122691), TCF15 (ENSG00000125878), FERD3L (ENSG00000146618), TCF23 (ENSG00000163792), HAND2 (ENSG00000164107), PTF1A (ENSG00000168267), MSC (ENSG00000178860), BHLHA9 (ENSG00000205899), TWIST2 (ENSG00000233608), SCX (ENSG00000260428), TCF24 (ENSG00000261787)
Protein
Protein identifiers
Factor in the germline alpha — Q6QHK4 (reviewed: Q6QHK4)
Alternative names: Class C basic helix-loop-helix protein 8, Folliculogenesis-specific basic helix-loop-helix protein, Transcription factor FIGa
All UniProt accessions (1): Q6QHK4
UniProt curated annotations — full annotation on UniProt →
Function. Germline specific transcription factor implicated in postnatal oocyte-specific gene expression. Plays a key regulatory role in the expression of multiple oocyte-specific genes, including those that initiate folliculogenesis and those that encode the zona pellucida (ZP1, ZP2 and ZP3) required for fertilization and early embryonic survival. Essential for oocytes to survive and form primordial follicles. The persistence of FIGLA in adult females suggests that it may regulate additional pathways that are essential for normal ovarian development. Binds to the E-box (5’-CANNTG-3’) of the ZPs (ZP1, ZP2, ZP3) promoters.
Subunit / interactions. Heterodimer with TCF3/isoform E12.
Subcellular location. Nucleus.
Tissue specificity. Germ cells. Expressed in the fetal ovary, but not by a range of other tissues. Expression increases across mid-gestation, rising some 40-fold by the time of primordial follicle formation.
Disease relevance. Premature ovarian failure 6 (POF6) [MIM:612310] An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. The disease is caused by variants affecting the gene represented in this entry.
RefSeq proteins (1): NP_001004311* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011598 | bHLH_dom | Domain |
| IPR036638 | HLH_DNA-bd_sf | Homologous_superfamily |
| IPR050283 | E-box_TF_Regulators | Family |
Pfam: PF00010
UniProt features (7 total): sequence variant 3, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6QHK4-F1 | 71.67 | 0.40 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 109 (showing top):
BENPORATH_ES_WITH_H3K27ME3, GOBP_OOGENESIS, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_OOCYTE_DIFFERENTIATION, GOBP_FEMALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_E_BOX_BINDING, QI_PLASMACYTOMA_DN, GOMF_TRANSCRIPTION_FACTOR_BINDING, GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr2p13
GO Biological Process (6): regulation of transcription by RNA polymerase II (GO:0006357), developmental process (GO:0032502), oocyte development (GO:0048599), cell differentiation (GO:0030154), positive regulation of transcription by RNA polymerase II (GO:0045944), oogenesis (GO:0048477)
GO Molecular Function (10): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), bHLH transcription factor binding (GO:0043425), protein dimerization activity (GO:0046983), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), E-box binding (GO:0070888)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), transcription regulator complex (GO:0005667)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| transcription by RNA polymerase II | 2 |
| germ cell development | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 1 |
| biological_process | 1 |
| oocyte differentiation | 1 |
| cellular developmental process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| female gamete generation | 1 |
| transcription cis-regulatory region binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor binding | 1 |
| protein binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
976 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FIGLA | NOBOX | O60393 | 978 |
| FIGLA | BMP15 | O95972 | 946 |
| FIGLA | SOHLH1 | Q5JUK2 | 943 |
| FIGLA | LHX8 | Q68G74 | 918 |
| FIGLA | FOXL2 | P58012 | 890 |
| FIGLA | YBX2 | Q9Y2T7 | 865 |
| FIGLA | POF1B | Q8WVV4 | 860 |
| FIGLA | GDF9 | O60383 | 821 |
| FIGLA | ZP1 | P60852 | 749 |
| FIGLA | ZP4 | Q12836 | 742 |
| FIGLA | ZP3 | P21754 | 734 |
| FIGLA | SOHLH2 | Q9NX45 | 734 |
| FIGLA | FMR1 | Q06787 | 722 |
| FIGLA | ZP2 | Q05996 | 720 |
| FIGLA | DIAPH2 | O60879 | 715 |
IntAct
39 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LHX8 | FIGLA | psi-mi:“MI:0915”(physical association) | 0.700 |
| FIGLA | LHX6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYOG | FIGLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYF5 | FIGLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYOD1 | FIGLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIGLA | TCF12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCF4 | FIGLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIGLA | LHX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIGLA | TCF23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FIGLA | TCF4 | psi-mi:“MI:0914”(association) | 0.350 |
| FIGLA | TCF3 | psi-mi:“MI:0914”(association) | 0.350 |
| FIGLA | LHX6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | MYOG | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | MYF5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | LHX8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | TCF4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | MYOD1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | TCF12 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FIGLA | LHX3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (20): FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), FIGLA (Two-hybrid), TCF4 (Two-hybrid), NES (Affinity Capture-MS), TCF12 (Affinity Capture-MS), ID4 (Affinity Capture-MS), TCF3 (Affinity Capture-MS), TCF4 (Affinity Capture-MS), LHX8 (Affinity Capture-MS)
ESM2 similar proteins: A0A287BDC1, A6NFD8, A8YXY8, B1AXD8, B3F209, F1LXF1, O00287, O14503, O35185, O35779, O35780, O54972, O77638, O95644, P11274, P12755, P36956, Q0D2I5, Q13469, Q3UR85, Q50H33, Q53H80, Q5EA15, Q5RAI7, Q60591, Q60611, Q60698, Q61976, Q6AYH2, Q6NS60, Q6QB00, Q6QHK4, Q6T4P5, Q6ZWB6, Q7TS99, Q7Z6J2, Q8BXL9, Q8N228, Q8R4T5, Q8TEK3
Diamond homologs: A8E5T6, B6VQA1, O13125, O13126, O16867, O35437, O42202, O42606, O43680, O57598, O60682, O73615, O73823, O88940, O93507, O96004, O96642, P13903, P17542, P22091, P24899, P26687, P46581, P48985, P48987, P57100, P57101, P57102, P59101, P61295, P61296, P70661, P79765, P79782, P97831, P97832, Q02575, Q02576, Q02577, Q0VCE2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 4 |
| Likely pathogenic | 2 |
| Uncertain significance | 42 |
| Likely benign | 11 |
| Benign | 26 |
Top pathogenic / likely-pathogenic (6)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2137 | NM_001004311.3(FIGLA):c.15_36del (p.Gly6fs) | Pathogenic |
| 2138 | NM_001004311.3(FIGLA):c.416ACA[1] (p.Asn140del) | Pathogenic |
| 3901241 | NM_001004311.3(FIGLA):c.339T>G (p.Tyr113Ter) | Pathogenic |
| 635131 | NM_001004311.3(FIGLA):c.2T>C (p.Met1Thr) | Pathogenic |
| 1256003 | NM_001004311.3(FIGLA):c.319C>T (p.Leu107Phe) | Likely pathogenic |
| 4292272 | NM_001004311.3(FIGLA):c.164C>A (p.Ser55Ter) | Likely pathogenic |
SpliceAI
753 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:70790407:CCCG:C | donor_gain | 1.0000 |
| 2:70790414:ACGCT:A | donor_gain | 1.0000 |
| 2:70790415:CG:C | donor_gain | 1.0000 |
| 2:70790415:CGCT:C | donor_gain | 1.0000 |
| 2:70790415:CGCTC:C | donor_gain | 1.0000 |
| 2:70790418:T:A | donor_gain | 1.0000 |
| 2:70785421:T:TA | donor_gain | 0.9900 |
| 2:70787735:T:TA | donor_gain | 0.9900 |
| 2:70790404:TCA:T | donor_loss | 0.9900 |
| 2:70790406:AC:A | donor_gain | 0.9900 |
| 2:70790407:C:A | donor_loss | 0.9900 |
| 2:70790407:CC:C | donor_gain | 0.9900 |
| 2:70790414:A:AC | donor_gain | 0.9900 |
| 2:70790415:C:CC | donor_gain | 0.9900 |
| 2:70790455:A:AC | donor_gain | 0.9900 |
| 2:70790456:C:CC | donor_gain | 0.9900 |
| 2:70785414:CCAGA:C | donor_gain | 0.9800 |
| 2:70785640:C:CC | acceptor_gain | 0.9800 |
| 2:70787802:C:CC | acceptor_gain | 0.9800 |
| 2:70790406:A:AC | donor_gain | 0.9800 |
| 2:70790407:C:CC | donor_gain | 0.9800 |
| 2:70787799:TATCT:T | acceptor_loss | 0.9700 |
| 2:70787801:TC:T | acceptor_loss | 0.9700 |
| 2:70787803:T:A | acceptor_loss | 0.9700 |
| 2:70789913:T:C | acceptor_gain | 0.9700 |
| 2:70790419:C:CA | donor_gain | 0.9700 |
| 2:70787638:TAC:T | donor_gain | 0.9600 |
| 2:70787639:ACA:A | donor_gain | 0.9600 |
| 2:70787640:CAC:C | donor_gain | 0.9600 |
| 2:70787804:AGAAA:A | acceptor_loss | 0.9600 |
AlphaMissense
1414 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:70787724:T:A | K103N | 0.996 |
| 2:70787724:T:G | K103N | 0.996 |
| 2:70787770:A:G | L88S | 0.996 |
| 2:70787725:T:A | K103I | 0.995 |
| 2:70787713:A:T | L107H | 0.994 |
| 2:70787705:C:G | A110P | 0.993 |
| 2:70787779:A:G | F85S | 0.993 |
| 2:70790416:G:T | R75S | 0.993 |
| 2:70787713:A:G | L107P | 0.992 |
| 2:70790415:C:G | R75P | 0.992 |
| 2:70790425:C:G | A72P | 0.992 |
| 2:70790409:C:G | R77P | 0.991 |
| 2:70787766:C:A | K89N | 0.989 |
| 2:70787766:C:G | K89N | 0.989 |
| 2:70787779:A:C | F85C | 0.989 |
| 2:70787727:G:C | S102R | 0.988 |
| 2:70787727:G:T | S102R | 0.988 |
| 2:70787729:T:G | S102R | 0.988 |
| 2:70790417:C:A | E74D | 0.988 |
| 2:70790417:C:G | E74D | 0.988 |
| 2:70787726:T:C | K103E | 0.987 |
| 2:70787791:A:G | L81P | 0.987 |
| 2:70790418:T:A | E74V | 0.987 |
| 2:70790420:C:A | K73N | 0.987 |
| 2:70790420:C:G | K73N | 0.987 |
| 2:70787696:A:G | Y113H | 0.986 |
| 2:70790419:C:T | E74K | 0.986 |
| 2:70787726:T:G | K103Q | 0.984 |
| 2:70787728:C:A | S102I | 0.984 |
| 2:70787704:G:T | A110E | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000268321 (2:70792177 C>G), RS1000385412 (2:70786686 T>C), RS1000735420 (2:70786445 C>A,T), RS1000766479 (2:70781540 C>A), RS1001125615 (2:70788047 C>G,T), RS1001164504 (2:70790637 A>C,G), RS1001270876 (2:70790806 G>C), RS1001500335 (2:70779075 T>C,G), RS1001791976 (2:70785231 G>A), RS1002473722 (2:70777493 A>C), RS1003507866 (2:70789575 A>G), RS1003560190 (2:70789767 A>C), RS1004110919 (2:70783377 C>A,T), RS1004183926 (2:70790042 C>G,T), RS1004376339 (2:70784125 A>T)
Disease associations
OMIM: gene MIM:608697 | disease phenotypes: MIM:612310
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| premature ovarian failure 6 | Strong | Autosomal recessive |
Mondo (1): premature ovarian failure 6 (MONDO:0012861)
Orphanet (1): Rare genetic premature ovarian failure (Orphanet:485382)
HPO phenotypes
30 total (30 of 30 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000013 | Hypoplasia of the uterus |
| HP:0000062 | Ambiguous genitalia |
| HP:0000133 | Gonadal dysgenesis |
| HP:0000144 | Decreased fertility |
| HP:0000252 | Microcephaly |
| HP:0000365 | Hearing impairment |
| HP:0000786 | Primary amenorrhea |
| HP:0000823 | Delayed puberty |
| HP:0000837 | Increased circulating gonadotropin level |
| HP:0000869 | Secondary amenorrhea |
| HP:0000938 | Osteopenia |
| HP:0001166 | Arachnodactyly |
| HP:0001251 | Ataxia |
| HP:0001470 | Sex-limited expression |
| HP:0001939 | Abnormality of metabolism/homeostasis |
| HP:0002206 | Pulmonary fibrosis |
| HP:0002225 | Sparse pubic hair |
| HP:0002750 | Delayed skeletal maturation |
| HP:0004322 | Short stature |
| HP:0004349 | Reduced bone mineral density |
| HP:0005625 | Osteoporosis of vertebrae |
| HP:0008209 | Premature ovarian insufficiency |
| HP:0008214 | Decreased serum estradiol |
| HP:0008222 | Female infertility |
| HP:0008232 | Elevated circulating follicle stimulating hormone level |
| HP:0008684 | Aplasia/hypoplasia of the uterus |
| HP:0009888 | Abnormality of secondary sexual hair |
| HP:0010311 | Aplasia/Hypoplasia of the breasts |
| HP:0010464 | Streak ovary |
| HP:0011969 | Elevated circulating luteinizing hormone level |
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002481_1 | Acne (severe) | 5.000000e-06 |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567351 | Premature Ovarian Failure 6 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects methylation | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Benzo(a)pyrene | increases methylation, decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A1U4 | SEES3-1V human FIGLA, clone1 | Embryonic stem cell | Male |
| CVCL_A1U5 | SEES3-1V human FIGLA, clone2 | Embryonic stem cell | Male |
| CVCL_A1U6 | SEES3-1V human FIGLA, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03178695 | PHASE1 | COMPLETED | Inovium Ovarian Rejuvenation Trials |
| NCT04009473 | PHASE1/PHASE2 | UNKNOWN | Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation |
Related Atlas pages
- Associated diseases: premature ovarian failure 6
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): premature ovarian failure 6